About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

Thermo Fisher Scientific Fuels the Future of Multi-omics Research with the Launch of Next-Generation Microarray Solution

New SwiftArrayStudio analyzer and updated genotyping arrays deliver results in as little as 30 hours, enabling researchers to drive impactful, scalable genetic research

Thermo Fisher Scientific, the world leader in serving science, has introduced the Applied Biosystems™ SwiftArrayStudio™ Microarray Analyzer, designed for fast and scalable sample analysis. In conjunction with two new arrays – the Applied Biosystems Axiom™ PharmacoPro™ Array and the Applied Biosystems Axiom PangenomePro Array – the analyzer combines four key genotyping processes into a single, integrated device, enabling researchers to cover the widest range of populations for Genome-Wide Association Studies (GWAS) and accelerate breakthrough discoveries in pharmacogenomics that will help drive the future of precision medicine forward.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251015327169/en/

New SwiftArrayStudio analyzer and updated genotyping arrays deliver results in as little as 30 hours, enabling researchers to drive impactful, scalable genetic research

New SwiftArrayStudio analyzer and updated genotyping arrays deliver results in as little as 30 hours, enabling researchers to drive impactful, scalable genetic research

As genetic science advances, researchers need faster, simpler ways to analyze samples. Traditional workflows can take days to complete and require extensive hands-on time. Large labs also face wide variability in customer needs, often demanding multiple instruments and specialized expertise to deliver results.

"The SwiftArrayStudio genotyping platform offers unique advantages, especially for comprehensive pharmacogenetics genotyping, major relevant pharmacogenetics genes with CPIC guidelines, plus many ADME genes for research applications with deep coverage of both common as well as rare variants, allowing for the identification of both rare and less frequent haplotypes,” said Ulrich Broeckel, MD, founder and chief executive officer of RPRD Diagnostics. “Combined with the ability to process medium to high sample throughput, this offers versatility that is advantageous for pharmacogenetics."

The SwiftArrayStudio Microarray Analyzer enables labs to be agile, seamlessly scaling throughput and optimizing performance as demand changes, without sacrificing data quality. The all-in-one platform delivers results in as little as 30 hours* through a modern, easy-to-use design that reduces hands-on time by up to 40 percent*. This efficiency lowers costs and complexity, helping researchers generate high quality data faster and with less effort.

“For decades, our innovations in genetic research and genomics have shaped the way scientists explore biology and delivered new capabilities to applied markets,” said Rosy Lee, president, genetic sciences, Thermo Fisher Scientific. “With this next-generation microarray platform, we are once again redefining what’s possible – leading the charge toward multi-omics and empowering researchers with a more complete view of biology that will accelerate discoveries in health and disease.”

The new SwiftArrayStudio analyzer redefines what microarray technology can offer. Its enhanced features and flexibility enable scientists to unlock new research initiatives, such as population-scale genotyping and pharmacogenomics, with hope in the future to bring treatments to individuals faster.

“The SwiftArrayStudio analyzer represents more than just technical advancement – it’s an advancement for genomics research, powering a new generation of innovation for our customers,” said Ravi Gupta, vice president and general manager of Thermo Fisher Scientific’s microarray business. “Designed as a single, expandable platform to meet future technological needs around genotyping, methylation, epigenetics, reproductive health, agrigenomics and many other applications, the platform delivers robust capabilities through an uncompromised user experience.”

The SwiftArrayStudio microarray analyzer will be on display in Thermo Fisher’s booth (#736) at the American Society of Human Genetics (ASHG) Annual Meeting in Boston, Mass., October 14–18. To learn more about the technology, please visit www.thermofisher.com/SAS.

This system and arrays are for research use only. Not for use in diagnostic procedures.

*According to internal data on file

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

“With this next-generation microarray platform, we are once again redefining what’s possible – leading the charge toward multi-omics and empowering researchers with a more complete view of biology that will accelerate discoveries in health and disease.”

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.